Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2026 Jan 23;16:6066. doi: 10.1038/s41598-026-37189-4

Structural characterization of metal binding in human tyrosylprotein sulfotransferase 2, TPST2

Minwoo Jin 1,2, Chaemin Noh 1,2, Jihyeong Yang 1,2, Hyunwoo Kim 1,2, Soo Bin Park 1, Yong-Chul Kim 1, Soo Hyun Eom 1,2,3,
PMCID: PMC12901059  PMID: 41571744

Abstract

Tyrosylprotein sulfotransferases (TPSTs) catalyze O-sulfation of tyrosine residues on secreted and membrane proteins, but the molecular basis for their stimulation by metal ions remains unclear. We determined the structures of the catalytic domain of human TPST2 with PAP and Na+ (1.75 Å) or Mn2+ (2.00 Å) bound and identified two conserved octahedral metal-binding sites. Anomalous diffraction at metal absorption edges confirmed the identity of the bound metals and demonstrated specific Mn2+ binding. The Na+- and Mn2+-bound structures closely superimposed, suggesting activation without large conformational changes. Structural comparison with the apo structure and ensemble refinement revealed differences in local dynamics around the metal binding sites. The flexible α3-helix and α12-α13 loop in the apo structure were stabilized by Na+ binding and further rigidified by Mn2+ binding. These findings support an activation-by-ordering mechanism in which Na+ binding generates a pre-activated state, with Mn2+ subsequently establishing a catalytically competent ordering that lowers the entropic barrier at the active-site entrance. This framework reconciles longstanding biochemical observations and suggests that Mn2+ availability within the Golgi can tune TPST2-dependent signaling.

Supplementary Information

The online version contains supplementary material available at 10.1038/s41598-026-37189-4.

Subject terms: Biochemistry, Biophysics, Chemistry, Structural biology

Introduction

Tyrosylprotein sulfotransferases (TPSTs) are enzymes localized within the trans-Golgi network and catalyze post-translational O-sulfation of tyrosine residues13. Using the universal sulfate donor 3′-phosphoadenosine-5′-phosphosulfate (PAPS), TPSTs transfer a sulfonyl group to the phenolic oxygen of tyrosine to form a tyrosine O-sulfate ester and 3′-phosphoadenosine-5′-phosphate (PAP)1,4,5 (Fig. 1). Protein tyrosine sulfation is widespread in metazoans, occurring predominantly along the secretory pathway68, where it modulates extracellular protein-protein recognition in diverse extracellular interactions, including hemostasis, leukocyte rolling and adhesion, chemokine-receptor signaling, viral entry, and hormone-receptor interaction911.

Fig. 1.

Fig. 1

Tyrosylprotein sulfation reaction catalyzed by TPST2. Schematic illustration of the PAPS-dependent sulfation reaction catalyzed by TPST2. The sulfonyl group from PAPS is transferred to the hydroxyl group of tyrosine to generate tyrosine O-sulfate and PAP.

Two human TPST isoforms, TPST1 (370 aa) and TPST2 (377 aa), have been identified. Both adopt the type II membrane protein topology with a short cytosolic N-terminus, single transmembrane helix, and luminal catalytic domain1214, and share the canonical sulfotransferase fold containing the conserved 5′-phosphosulfate binding (5′-PSB) and 3′-phosphate binding (3′-PB) motifs1517 (Supplementary Fig. 1). Biochemical and mutational studies have shown that TPSTs preferentially recognize acidic sequence motifs flanking the acceptor Tyr site, with Asp/Glu residues within ± 5 positions1820. The high-resolution crystal structure of human TPST2 bound to PAP and a C4-derived peptide (C4P5Y3) defined the peptide-binding cleft and clarified the catalytic mechanism of the tyrosine sulfation16. Complementary analyses of human TPST1 structures, together with enzymatic characterization, provided additional insight into their substrate specificity and isoform-dependent differences in recognition17. More recently, the crystal structure of tick TPST in complex with PAP and a madanin-derived peptide revealed a sequential sulfation mechanism in which sulfation of Tyr51 facilitates subsequent modification of Tyr54, providing comparative insight into substrate recognition across TPSTs21. Together, these structural studies characterize the molecular framework of TPST isoforms and highlight the conserved catalytic features underlying substrate recognition and function.

TPST2 exhibits distinct physiological and pathological properties. Tpst2-deficient mice exhibit primary hypothyroidism, growth delay and male infertility, which demonstrate the enzyme’s essential contribution to thyroid hormone biosynthesis and reproductive function2224. TPST1 and TPST2 differ in their tissue distributions and enzymatic properties, which is consistent with their isoform-specific substrate preferences17,25. In addition, recent studies have shed light on the significance of TPST2 in disease. In melanoma, for example, TPST2 sulfates IFNGR1 at Tyr397 to suppress IFN-ɣ signaling, and the absence of TPST2 enhances the efficacy of PD-1 blockade, implicating the enzyme in tumor immune evasion26. In pancreatic ductal adenocarcinoma, the SLC35B2-TPST2 axis promotes tumor growth and metastasis, with integrin β4 identified as a TPST2 substrate whose sulfation stabilizes the protein27. Conversely, TPST2 inhibition reduces cancer cell proliferation, migration, invasion and metastasis. In parallel, the recent development of antibodies that specifically recognize sulfotyrosine provides powerful tools for probing TPST-mediated signaling in physiological and pathological contexts28. These findings establish TPST2 as a critical regulator of extracellular signaling and tumor biology and underscore the need to define the molecular basis of its regulation.

A characteristic biochemical property of TPSTs is stimulation by divalent metals18,19,29,30. Early enzymatic assays demonstrated that tyrosine sulfation is markedly enhanced in the presence of Mn2+ or Mg2+, indicating the requirement of divalent ions for maximal activity18,19. Assays with recombinant enzymes revealed that activation is isoform specific with TPST2, but not TPST1, responsive to Mg2+, and the optimal MnCl2 level and maximal activation differing between the two isoforms25. Comparative enzymology further revealed that Mn2+ significantly enhances the catalytic efficiency of human TPST2. Optimal activity for some substrates was observed at low millimolar concentrations of MnCl2, though the extent of the stimulation depended strongly on the peptide sequence and buffer composition30. Despite these biochemical observations, the molecular basis of metal activation remains unclear, and a structural framework for understanding how Mn2+ enhances TPST2 activity has not been established. These uncertainties highlight the necessity for direct structural and dynamics-based investigations into metal binding to TPST2.

Here, we determined the crystal structures of human TPST2 with mono- and divalent metal ions. We determined their ion specificities through anomalous diffraction analysis for Mn2+, Co2+, Zn2+ and Cu2+, and we assessed local flexibility using per-residue root-mean-square fluctuation (RMSF) analysis. Our results demonstrate that Mn2+ and Co2+ selectively occupy two conserved octahedral sites, reduce conformational fluctuations in the α3-helix and α12-α13 loop, and enhance local stability without inducing global structural changes. These findings provide a structural basis for understanding the metal-dependent activation of TPST2 and support a model in which divalent metal binding reduces the entropic barrier for catalysis by stabilizing key elements of the active site.

Results

Structure determination of Na+-bound TPST2 and identification of two metal-binding sites

The catalytic domain of human TPST2 (residues 43–359; hTPST2) was overexpressed in E. coli (Fig. 2a and Supplementary Fig. 2a). The enzymatic activity of hTPST2 was assessed in an in vitro sulfotransferase assay, which confirmed that the recombinant catalytic domain retained activity in the absence of the transmembrane anchor and cytosolic tail (Supplementary Fig. 3). To obtain diffraction-quality crystals of hTPST2, co-crystallization with PAP was essential. We determined the structure of Na+-bound TPST2 (TPST2Na) in complex with PAP at 1.75 Å resolution using molecular replacement with Rwork and Rfree values of 17.1% and 18.7%, respectively (Table 1).

Fig. 2.

Fig. 2

Overall structure of TPST2 in the cation-bound state. (a) Domain organization of human TPST2, which consists of a transmembrane helix (TM), stem region (S) and luminal catalytic domain. The catalytic domain used for crystallization is colored cyan. b, c Cartoon representations of TPST2Na monomer (b) and dimer (c). The two protomers are colored cyan and pink, with β-sheets highlighted in lime green. Bound Na+ and Zn2+ ions are shown as purple and gray spheres, respectively. PAP, glycerol (GOL), and tartrate (TLA) are shown as white sticks. d Stereo view of cation-binding sites 1 and 2. Coordinating residues are shown as sticks, Na+ ions as purple spheres, and water molecules are red spheres.

Table 1.

Data collection and refinement statistics.

TPST2Na (PDB: 9WWE) TPST2Mn (PDB: 9WWF) Mn (ano) Co (ano) Zn (ano) Cu (ano)
Data collection
Wavelength (Å) 1.0000 0.9794 1.8933 1.6054 1.2824 1.3785
Space group P4122 P4122 P4122 P4122 P4122 P4122

Unit cell:

a, b, c (Å)

α, β, ɣ (°)

102.3, 102.3, 103.6

90.0, 90.0, 90.0

102.8, 102.8, 103.1

90.0, 90.0, 90.0

102.8, 102.8, 103.0

90.0, 90.0, 90.0

102.6, 102.6, 103.7

90.0, 90.0, 90.0

102.6, 102.6, 104.0

90.0, 90.0, 90.0

102.8, 102.8, 102.8

90.0, 90.0, 90.0

Resolution range (Å)

46.2–1.75

(1.79–1.75)

46.1–2.00

(2.05–2.00)

46.1–2.20

(2.27–2.20)

46.3–2.30

(2.38–2.30)

50.0–2.30

(2.34–2.30)

50.0–2.40

(2.44–2.40)

R merge a 14.4 (123.5) 17.6 (84.0) 16.6 (85.2) 16.8 (100.1) 20.2 (122.1) 22.8 (97.1)
R pim 2.8 (24.1) 3.6 (17.0) 3.5 (25.1) 3.4 (20.1) 4.1 (25.3) 4.6 (22.4)
CC1/2 0.999 (0.760) 0.999 (0.873) 0.998 (0.700) 0.999 (0.908) 0.982 (0.873) 0.977 (0.871)
I/σ(I) 18.7 (3.5) 24.4 (10.8) 16.0 (3.2) 19.5 (4.3) 20.5 (2.7) 17.4 (2.1)
Completeness (%) 100.0 (99.2) 99.9 (99.3) 99.2 (92.3) 100.0 (99.7) 100.0 (100.0) 99.9 (99.4)
Redundancy 26.8 (26.3) 25.0 (25.1) 23.0 (11.8) 25.2 (25.5) 25.5 (24.2) 24.6 (18.4)
Refinement
Resolution (Å) 46.2–1.75 46.1–2.00
No. unique reflections 55,401 (3864) 37,847 (2860)
Rwork/Rfreeb (%) 17.0/18.6 18.3/22.6
No. atoms 2682 2686
Protein 2377 2359
Ligands 47 42
Solvent 258 285
B-factors
Protein 23.4 17.5
Ligands 22.8 27.9
Solvent 34.0 30.9
R.m.s. deviations
Bond lengths (Å) 0.006 0.007
Bond angles (°) 1.23 1.22
Ramachandran plot (%)
Favored/allowed/disallowed 98.3/1.7/0.0 98.0/2.0/0.0

Values in parentheses are for the highest resolution shell.

aRmerge = ΣhΣi | I(h)i − ‹I(h)›|/[ΣhΣi I(h)i], where I(h) is the intensity of reflection of h, Σh is the sum over all reflections, and Σi is the sum over i measurements of reflection h.

bRwork = Σhkl ||Fo | − |Fc | |/(Σhkl | Fo | ); 5% of the reflections were excluded for the Rfree calculation.

Inspection of σA-weighted mFo-DFc maps above 8σ revealed two well-ordered metal densities with octahedral coordination geometry, hereafter referred to as metal-binding site 1 and site 2 (Fig. 2b; Table 2). To evaluate which metals were most plausible at sites 1 and 2, we analyzed both positions using the CheckMyMetal31 (CMM) and MetalPDB32 servers. CMM analysis favored Na+ assignments for both metal-binding sites, with all stereochemical and geometric parameters within acceptable or borderline ranges for Na+ (Supplementary Fig. 4). When K+ was modeled at this position, the refined B factor of the ion (~ 32 Å2) was substantially greater than those of the coordinating atoms and surrounding residues. In addition, average coordination distances (2.6 Å) and B-factor ratios were consistent with Na+. Taken together with the high sodium content of the mother liquor (~ 120 mM), we modeled two metal-binding sites as Na+ within TPST2Na.

Table 2.

Crystallization conditions and electron density features of TPST2 structures.

TPST2Na (PDB: 9WWE) TPST2Mn (PDB: 9WWF) TPST2pep (PDB: 3AP1) TPST2apo (PDB: 3AP3) Co (ano) Zn (ano) Cu (ano)
Cation concentration (mM)
Na 120 120 300 200 120 120 120
K 100 100 - - 100 100 100
Zn 25 1 - - 1 10 1
Mn - 20 1 1 - - -
Co - - - - 10 - -
Cu - - - - - - 10
Peak height (2FoFc / anomalous; σ)
Metal binding site 1 8.1 / NA 5.8 / 8.5 2.6 / - - / - 5.1 / 5.2 4.3 / - 3.7 / -
Metal binding site 2 10.1 / NA 7.6 / 5.8 5.2 / - - / - 4.5 / 3.5 4.3 / - 3.4 / -
Crystallographic lattice site 1 28.5 / NA 23.3 / 10.7 - / - - / - 16.8 / 5 13.3 / 46.0 14.6 / -
Crystallographic lattice site 2 20.3 / NA - / - - / - - / - - / - 4.2 / 9.3 - / -

Values indicate crystallization cation concentrations and corresponding 2Fo-Fc / anomalous peak heights (σ) observed at metal-binding or lattice sites.

The TPST2Na monomer consisted of three consecutive α-helices and a single α/β motif with a five-stranded parallel β-sheet (Fig. 2b). PAP occupied the canonical 5′-PSB and 3′-PB subsites in a pose consistent with previously reported human TPST2 structures16 (Supplementary Fig. 5). Two lattice-associated metal densities were identified at crystal-packing interfaces but were not positioned to contribute directly to catalysis (Supplementary Fig. 6). The asymmetric unit contained one TPST2 protomer, and the physiological dimer was generated by crystallographic symmetry (Fig. 2c). Together, these results establish a well-ordered PAP-bound TPST2Na structure with two coordinated Na+ ions positioned within the catalytic domain.

Structural conservation and divergence of TPST2 metal-binding sites

We next examined the coordination environments of the two metal-binding sites (Fig. 2d). Site 1 was located near the C-terminus of the α3-helix at the dimer interface. Its coordination sphere comprised the Glu98 side chain, main-chain carbonyl oxygens of Glu125 and Leu279, and three water molecules. Site 2 was positioned near the C-terminus of the α1-helix, adjacent to the 5′-PSB region. This site was coordinated by main-chain carbonyl oxygens from Asp89, His91, Val94 and Gly275 together with two water molecules. The structural definition of the two metal-binding sites in TPST2 provides a framework with which to evaluate the conservation of coordinating residues across TPST homologs.

We analyzed representative TPST sequences and compared the TPST2Na structure with TPST1 (PDB 5RWI) and tick TPST (PDB 8W5Z) structures (Fig. 3a and b). Site 1 residues (Glu98, Glu125, and Leu279) were strictly conserved across TPST homologs, which is consistent with an invariant coordination environment. This site was clearly occupied by Na+, whereas other TPST structures had not assigned a metal at this position. These findings indicate that although site 1 is strongly conserved, it is associated with a comparatively dynamic coordination environment. Consistent with this interpretation, CMM analysis showed higher B-factors for both the Na+ ion and its coordinating residues at site 1 than site 2 (site 1: 21.7 and 34.5; site 2: 17.0 and 20.3) (Supplementary Fig. 4).

Fig. 3.

Fig. 3

Conservation of cation binding sites across TPST homologs. (a) Multiple sequence alignment of TPST homologs highlighting residues forming cation-binding sites 1 and 2. Coordinating residues at sites 1 and 2 are boxed in green and yellow, respectively. Catalytic residues, peptide-binding residues, and dimerization-related residues are marked with red, blue and black stars, respectively. Sequence conservation is represented by a purple gradient. b Detailed view of superimposed cation-binding sites 1 and 2 in human TPST2Na (cyan), TPST1 (green; PDB 5WRI) and tick TPST (yellow; PDB 8W5Z). Na+ ions are shown as purple spheres, and coordinating residues are depicted as sticks.

The loop region surrounding site 2 showed notable divergence. While TPST2 and TPST1 shared well-superimposed coordinating residues, the tick TPST exhibited a shortened α12-α13 loop and lacked the conserved Gly275 that participates in metal coordination at site 2 (Fig. 3b). Nevertheless, in all three structures the ligands around site 2 assumed a comparable octahedral coordination geometry (Supplementary Fig. 7). Broader sequence alignments further revealed that in invertebrate homologs, this region is either truncated or lacking the equivalent Gly275 (Fig. 3a). These observations suggest that, although the local coordination environment of site 2 is conserved, the surrounding loop region is more variable than at site 1 and may contribute to species-dependent differences in metal-dependent activation.

Metal-binding profile by single-wavelength anomalous diffraction

Biochemical assays have established that Mn2+ strongly activates TPST2 activity25,30. To structurally define this effect, we determined the Mn2+-bound structure (TPST2Mn) in complex with PAP at 2.00 Å resolution and Rwork and Rfree values of 18.3% and 22.5%, respectively (Table 1; Fig. 4a). We also collected single-wavelength anomalous diffraction (SAD) data at the Mn K-edge (λ = 1.8933 Å) (Table 1). The anomalous difference map displayed two strong peaks corresponding to metal-binding sites, 8.5σ at site 1 and 5.8σ at site 2 (Fig. 4b). The corresponding 2Fo-Fc map densities were 5.8σ and 7.6σ, respectively. These results indicate that Mn2+ occupied both sites. The relative difference between the anomalous and 2Fo-Fc peak heights further suggested that site 1 had higher occupancy but exhibited greater mobility, while site 2 had lower occupancy within a more rigid coordination environment.

Fig. 4.

Fig. 4

Selective Mn2+ binding detected by anomalous diffraction in TPST2. (a) Stereo view of the TPST2Mn dimer structure shown as a cartoon representation. The two protomers are colored green and orange. Site 1; cation-binding site 1, Site 2; cation-binding site 2, LS; crystallographic lattice site 1 (b) Close-up view of cation-binding sites 1 and 2 in human TPST2Mn. Mn2+ anomalous and 2Fo-Fc electron density maps are shown in dark blue and light blue, respectively. The anomalous map is contoured at 5.0 σ, and the 2Fo-Fc map at 1.5 σ, with peak heights labeled below. Bound Mn2+ ions are shown as light violet transparent spheres, and coordinating residues are represented as sticks. Water molecules are depicted as red spheres and labeled w.

To probe ion selectivity, we collected additional SAD datasets from TPST2Na crystals soaked with 10 mM CoCl2, ZnCl2 or CuCl2 at wavelengths close to the K-edge of each element (ƛ = 1.6054 Å, 1.2824 Å, and 1.3785 Å, respectively) (Table 1). Anomalous difference Fourier maps were then inspected at the metal-binding sites to assess the presence of metal-specific signals (Table 2). Fourier-difference anomalous maps displayed Co2+ signals of 5.2σ at site 1 and 3.5σ at site 2 (Supplementary Fig. 8). Zn2+ produced no signal at either site but instead localized to packing sites enriched in histidine and acidic residues (Supplementary Fig. 9). Cu2+ datasets showed only weak (< 2σ) and spatially diffuse peaks inconsistent with specific binding. Structural alignment of TPST2Na, TPST2Mn, and soaking structures showed nearly identical coordinates with a monomer root mean square deviation (RMSD) of ~ 0.1 Å and dimer RMSD of ~ 0.2 Å (Supplementary Fig. 10). Those findings indicate that TPST2 did not undergo large conformational changes upon metal binding. Thus, the anomalous mapping established that TPST2 selectively binds Mn2+ at its two sites, though it also weakly binds Co2+. Zn2+ and Cu2+ failed to occupy these positions. This selectivity is consistent with biochemical kinetic observations that Mn2+ strongly activated TPST225, while Zn2+ produced little stimulation of enzymatic activity29.

Comparisons with metal unbound TPST2 structures

To further assess the impact of Mn2+ binding, we compared TPST2Mn with previously reported human TPST2 structures representing peptide-bound (TPST2pep, PDB 3AP1) and apo (TPST2apo, PDB 3AP3) states. Monomer overlays revealed small RMSDs (~ 0.3 Å), confirming that the catalytic core remained pre-organized across PAP-bound states (Fig. 5a; Table 3). However, when we aligned one protomer of the dimer, the opposing catalytic domain of the protomer displayed a modest rigid-body shift of ~ 3–6 Å among states (Fig. 5b). The TPST2apo structure positioned the opposing catalytic domain lowest, whereas the TPST2Mn and TPST2pep structures shifted the protomer toward the substrate peptide cleft.

Fig. 5.

Fig. 5

Structural comparison of TPST2Mn with TPST2apo and TPST2pep. (a) Cartoon representation of the superimposed TPST2Mn (orange), TPST2pep (teal; PDB 3AP1) and TPST2apo (pale cyan; PDB 3AP3) monomers. Mn2+ ions are shown as light violet spheres. (b) Structural comparison of TPST2 dimers. Structures are aligned based on one protomer, which is shown as a surface representation. The rigid-body shift is indicated by a black arrow. The substrate peptide binding cleft is marked by an orange sector. (c) Close-up view of substrate peptide cleft in the superposed structures. PAP is shown as sticks in the nucleotide pocket, and the C4 peptide is shown as a cartoon with the acceptor tyrosine as stick. (d) Close-up view of cation-binding site 1 in the superposed structures. Mn2+ ions are shown as light violet spheres, and coordinating residues are represented as sticks. The distance between Glu125 and Leu279 is indicated by a dotted line and labeled.

Table 3.

RMSD values between TPSTMn and other TPSTs structures.

RMSD (Å) Human TPST2 Human TPST1 Tick TPST
3AP1 3AP2 3AP3 5WRI 5WRJ 8W5Z
Monomer (A/B) 0.21/0.33 0.27/0.38 0.36/0.37 0.43/0.46 0.43/0.45 0.48/0.51
Dimer 0.65 0.91 0.61 1.81 1.55 0.66

Within the TPST2pep structure, a short βe has an antiparallel interaction with the substrate peptide. By contrast, within the TPST2Mn and TPST2apo structures, which lacked a substrate peptide, βe was positioned farther from the cleft (Fig. 5c). The TPST2Mn structure differed in that the α12-α13 loop shifted toward the active site and stabilized the α3-helix in an ordered conformation, despite the absence of the substrate peptide (Fig. 5c). At site 1, the α12-α13 loop was positioned closer to the α3-helix in TPST2Mn than in the other structures, which shortened the carbonyl-oxygen distance between Glu125 and Leu279 (4.4 Å vs. 5.3 and 5.1 Å) (Fig. 5d). Furthermore, site 1 was located at the C-terminal end of the α3-helix, suggesting that Mn2+ binding stabilizes the helix dipole. Consistent with that interpretation, the α3-helix was disordered in the TPST2apo structure, and the α2-α3 kink (residues 112–117) also adopted multiple conformations within the TPST2pep structure16.

These observations indicate that Mn2+ binding at site 1 stabilizes the dimer interface and preserves the integrity of the α3-helix without introducing large-scale conformational rearrangements. Notably, previous TPST2 structures were crystallized under high Na+ conditions (> 200 mM), yet no Na+ ions were modeled at the binding sites, and the α3-helix appeared less ordered. This likely reflects incomplete or heterogeneous Na+ occupancy together with resolution limitations, rather than a true absence of bound ions. By contrast, our TPST2Na structure captured clear ion densities and displayed a stabilized α3-helix. These observations indicate that sufficient cation occupancy can promote structural ordering and suggest that our Na+-bound structure represents a cation-stabilized form of TPST2.

Metal-dependent dynamics and stability

To further validate the stabilizing effect of metal binding indicated by the structural comparisons, we next examined the thermal stability of hTPST2 under Na+- and Mn2+-bound conditions. The melting temperature (Tm) of hTPST2 in the Mn2+-bound state (Mn; 49.7 ± 0.3 °C) was higher than in the Na+-bound state (Na; 47.6 ± 0.1 °C) (Fig. 6a). We then performed ensemble refinement followed by per-residue RMSF analysis with Z-normalization (Z-RMSF) (Fig. 6b). Two regions showed lower Z-RMSF upon metal binding: the α3 helix (residue 109–126) and the α12-α13 loop (residue 261–285) (Fig. 6c). Notably, Ser116 at the α2-α3 kink and Gly275 at site 2 exhibited the most significant reductions upon Mn2+ binding. Both residues showed > 1.5σ fluctuations in the TPST2pep structure relative to TPST2Mn. Although not directly comparable due to its lower resolution, the TPST2apo structure nevertheless displayed a high degree of flexibility in both regions with Z-RMSF values exceeding 2.0σ, which is similar to the TPST2pep state (Supplementary Fig. 11a). Taken together, these results demonstrate that metal binding decreases the flexibility of the α3 helix and α12-α13 loop, consistent with the structural comparisons described above.

Fig. 6.

Fig. 6

Metal binding increases thermal stability and reduces local flexibility of TPST2. (a) Thermal-shift assay of TPST2 in Na+ (blue) or Mn2+ (green). UV absorbance at 470 nm was measured across temperatures to determine Tm. Symbols show the mean ± 95% CI (n = 3). Dose-response curve fitting is shown as a black line. Calculated Tm values are indicated at right. b Per-residue Z-RMSF derived from ensemble refinement for TPST2Na (blue), TPST2Mn (green) and TPST2pep (grey). Secondary-structure elements are annotated above. Beige and gray shading marks regions where Z-RMSF values are lower in TPST2Mn than in TPST2pep. c Representations of the RMSF based on ensemble refinements of TPST2Na, TPST2Mn and TPST2pep. Colors denote RMSF from 0 Å (blue) to 4 Å (red).

To complement the crystallographic analysis, we sampled TPST2 dynamics using BioEmu33 and computed RMSF profiles across states (Supplementary Fig. 11b). Predicted flexible regions (RMSF > 2 Å) included the N-terminus (43–63), the α3-helix (112–131), the βe (196–202), the α12-α13 loop (272–296), and the C-terminus (339–359) (Supplementary Fig. 11c). These regions overlapped closely with ensemble-refined high Z-RMSF regions from crystallography, especially the α3-helix and α12-α13 loop regions (Fig. 6b). Overall, our anomalous mapping, structural comparisons and ensemble-based dynamics analysis converge on a mechanism in which Mn2+ occupancy at the two octahedral sites reduces the flexibility of the α3-helix and the α12-α13 loop. This stabilization is reflected in the Tm and RMSF values and supports a model in which metal binding reduces conformational variability without inducing large conformational changes (Fig. 7).

Fig. 7.

Fig. 7

Proposed model for metal-dependent activation of TPST2. The top panel shows a metal-free TPST2 state but no ordered cations at the two conserved sites. Binding of Na+ (purple) to these sites stabilizes the α3 helix and the α12-α13 loop and yields a pre-organized conformation with modest catalytic activity. Binding of Mn2+ (light violet) further stabilizes these elements and corresponds to a more fully activated state that promotes efficient sulfation of acidic peptide substrates. Arrows indicate reversible association of Na+ and Mn2+.

Discussion

Protein tyrosine sulfation is a prevalent post-translational modification that regulates diverse extracellular signaling processes. TPSTs catalyze this reaction by transferring a sulfonyl group from PAPS to tyrosine residues, preferentially recognizing acidic motifs surrounding the target tyrosine (Fig. 1). Among the two human isoforms, TPST2 has been implicated in such physiological processes as thyroid hormone biosynthesis and reproduction as well as in pathological contexts that include tumor immune evasion and metastasis progression. Although TPST stimulation by divalent metals was first described decades ago, the molecular mechanism underlying this activation remained unresolved. In the present study, we identified two conserved metal-binding sites in TPST2 and demonstrated their structural and dynamic contributions to catalytic regulation.

Anomalous diffraction analysis revealed that Mn2+ is selectively bound to both metal-binding sites (Fig. 2b). Co2+ exhibited only weak binding, while Zn2+ and Cu2+ did not bind productively (Supplementary Figs. 8 and 9). The inability of Zn2+ to substitute for Mn2+ is consistent with its preference for tetrahedral coordination, which explains the lack of TPST2 activation by Zn2+ in biochemical assays. By contrast, Mn2+ stabilizes both the α3-helix at the dimer interface and the α12-α13 loop adjacent to the active site, which reduces conformational fluctuations and facilitates catalysis (Figs. 5 and 6). These findings provide a structural rationale for longstanding biochemical observations that Mn2+ strongly enhances TPST2 activity. Although Mg2+ has also been reported to activate TPST2 to a limited extent25 and was present in our assay buffer, the structural analysis presented here focuses on Mn2+-dependent activation. Because the Mn2+ concentrations in the Golgi lumen are thought to lie in the low-micromolar range, quantitative measurements of metal-binding affinities and site occupancy will be required to define how strongly TPST2 is activated under physiological conditions.

Direct comparison of the structures of Na+- and Mn2+-bound TPST2 showed that their overall conformations are nearly identical, indicating that metal-stimulated activity is not driven by large-scale rearrangements (Supplementary Fig. 10). Instead, stabilization occurs through modulation of local dynamics, particularly within the α3 segment and the α12-α13 loop. Using ensemble refinement, we observed that Mn2+ occupancy dampens fluctuations in these regions and that Na+ binding produced a comparable stabilizing effect (Fig. 6b). Notably, previously reported TPST2 structures crystallized under high-NaCl conditions did not reveal clear ion densities16. This likely reflects partial occupancy or resolution limitations. By contrast, our Na+-bound structure captured well-defined cation densities and a stabilized α3-helix, suggesting it represents a metal-stabilized form of TPST2 (Fig. 2d). These findings support an activation-by-ordering model in which a divalent metal, especially Mn2+, reduces the entropic cost of catalysis by pre-organizing flexible structural elements at the active-site entrance (Fig. 7).

Together with thermal stability and dynamics analyses, these results support a model in which there are three metal-dependent states (Fig. 7). In the metal-free state, the α3-helix and α12-α13 loop remain flexible and the enzyme lacks full catalytic competence. Under Na+-rich conditions, Na+ can occupy the two octahedral sites at sufficient occupancy to promote partial ordering of the α3-helix. This metal-stabilized form of TPST2 likely represents a partially activated conformation in which structural elements are restrained but catalytic efficiency remains modest due to the weak coordination strength of monovalent ions. Full activation occurs upon the binding of Mn2+ (or Co2+), which engage both sites with stronger coordination geometry. This stabilizes the α3-helix dipole and the α12-α13 loop more effectively, lowering the entropic barrier for catalysis and priming the enzyme for recognition of acidic peptide substrates. Thus, metal binding does not induce large conformational transitions but shifts TPST2 toward an ordered, catalytically competent state by stabilizing local elements at the active-site entrance. The precise order of PAP/PAPS and metal binding during this cycle remains unresolved; future kinetic and thermodynamic studies will be needed to clarify how metal ions modulate cofactor and substrate recognition by TPST2 and to delineate the potential contribution of each of the cation-binding sites.

Beyond their structural significance, these findings carry potential physiological and pathological implications. TPST2 activity has been shown to modulate interferon receptor signaling in melanoma and to stabilize integrin β4 in pancreatic cancer, thereby promoting immune evasion and metastatic progression26,27. Our results suggest that local metal ion availability, particularly the Mn2+ concentration within the Golgi lumen, may directly influence TPST2 activity in cells. Other studies indicate that the Golgi apparatus functions as a major intracellular Mn2+ store and that the luminal Mn2+ pool is enriched but tightly controlled in the low-micromolar range, where small changes are sufficient to modulate Mn2+-dependent enzymes and glycosylation3437. Perturbations in Mn2+ homeostasis, which have been associated with metabolic disorders and cancer, could therefore intersect with TPST2-mediated pathways and contribute to disease outcomes. This possibility highlights a regulatory axis linking cellular ion balance with extracellular signaling via protein sulfation. In addition, our comparative analysis suggests that conservation of the metal-binding sites varies among species, implying that the extent of metal-dependent regulation may not be universal and warrants further investigation.

In summary, we determined the structural basis of metal binding in human TPST2 and revealed that Mn2+ occupancy enhances enzyme activity by stabilizing flexible elements near the active site. This dynamics-centered mechanism explains the metal dependence of TPST2 and rationalizes the selective activation by Mn2+. These findings integrate structural, biochemical, and pathological perspectives, establishing a foundation for future studies on how TPST2 couples metal ion regulation to extracellular signaling and disease processes.

Materials and methods

Cloning, expression, and purification of hTPST2

Human TPST2 (hTPST2, residues 43–459, UniProt ID: O60704) was codon-optimized for Escherichia coli and synthesized (GenScript). hTPST2 was subcloned into modified pET23b (Novagen) vector containing an N-terminal His6-tag and maltose binding protein (MBP) followed by a TEV protease cleavage site. The recombinant vectors were transformed into Rosetta-gami 2 (DE3) pLysS cells, which were then grown in Luria-Bertani (LB) medium containing 50 µg/mL kanamycin at 37 °C until the UV absorbance at 600 nm was 0.6. Recombinant proteins were expressed under induction with 0.5 mM isopropyl-D-thiogalactoside (IPTG) at 20 °C for 20 h.

Cells were harvested and lysed by sonication in buffer A [50 mM Tris-HCl (pH 7.5), 500 mM NaCl, 40 mM imidazole, 5 mM β-mercaptoethanol (β-ME), 0.3% (v/v) Triton X-100 and 1 mM phenylmethylsulfonyl fluoride]. Clarified lysates were centrifuged at 15,184 x g at 4 °C for 1 h., after which the supernatant was collected and applied to an Econo-Cloumn (Bio-Rad) packed with Ni-NTA agarose resin pre-equilibrated with buffer A. After washing with buffer A, protein was eluted with buffer B [50 mM Tris-HCl (pH 7.5), 500 mM NaCl, 500 mM imidazole and 5 mM β-ME]. The eluted protein was concentrated to 2 mg/mL using an Amicon Ultra-15 50 K (Millipore, Merck), and the His6-MBP tag was cleaved with TEV protease at 4 °C for 14 h along with dialysis against buffer C [20 mM Tris-HCl (pH 8.0), 300 mM NaCl and 5 mM β-ME]. After dialysis, hTPST2 were eluted using increasing concentrations of imidazole in buffer C in a second NI-NTA affinity chromatography step. The fractions containing the hTPST2 were collected and concentrated using an Amicon Ultra-15 30 K (Millipore, Merck) followed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). hTPST2 was then subjected to size-exclusion chromatography (SEC) on a HiLoad 16/60 Superdex 75 prep grade column (Pharmacia) pre-equilibrated with buffer D [20 mM Tris-HCl (pH 7.5), 100 mM NaCl]. The peak fractions were collected, concentrated to 2.2 mg/mL and stored at − 80 °C.

Crystallization and soaking experiments

Prior to crystallization, PAP was added to the purified hTPST2 to a final concentration of 0.5 mM and incubated on ice for 30 min. Initial crystallization screening was carried out using the sitting-drop vapor diffusion method at 20 °C in a 96-well INTELLI-PLATE (Art Robbins Ins.). Drops were prepared by mixing 0.2 µL of hTPST2 (2.0 mg/mL) and 0.2 µL of reservoir solution. Microcrystals formed after 3 days in Pact premier 1 & 2 Screen C12 [0.1 M HEPES-NaOH (pH 7.0), 20% (w/v) PEG 6000 and 10 mM ZnCl2] reservoir solution. Additional crystallization trials were performed using a 24-well Cryscheme plate (Hampton) by mixing 2 µL of protein and 2 µL of reservoir solution. Optimized TPST2Na and TPST2Mn crystals were respectively obtained in reservoir solutions containing 0.1 M HEPES-NaOH (pH 7.0), 16% (w/v) PEG 6000, 25 mM ZnCl2 and 0.1 M potassium sodium tartrate​ or in 0.1 M HEPES-NaOH (pH 7.0), 14.2% (w/v) PEG 6000, 1 mM ZnCl2, 20 mM MnCl2 and 0.1 M potassium sodium tartrate​. Crystals were cryoprotected in mother liquor supplemented with 20% (w/v) glycerol before flash freezing in liquid nitrogen.

Data collection, structure determination, and refinement.

Diffraction data were collected at 100 K using a synchrotron X-ray source on beamlines 5 C and 11 C at the Pohang Accelerator Laboratory (PAL) (Pohang, Korea). The best resolution diffraction data for TPST2Na and TPST2Mn were collected at 1.75 Å and 2.00 Å resolution, respectively. Diffraction data were collected at wavelengths of 1.0000 Å (TPSTNa), 0.9794 Å (TPSTMn), 1.8933 Å (Mn K-edge), and additional energies corresponding to the Co, Zn and Cu K-edges. Data indexing, integration and scaling were performed using XDS package38 and HKL suite39. All crystals were in the tetragonal space group P4122. Structures were solved using molecular replacement with Phaser-MR40 in the PHENIX package41 with TPST2 (PDB ID: 3AP1) as the template. Iterative refinement was performed with phenix.refine in the PHENIX package and REFMAC5 in the CCP4i suite42, and model building was carried out in Coot43. The coordinates and structural factors were deposited in the PDB RCSB with an accession code of 9WWE for TPST2Na and 9WWF for TPST2Mn.

Soaking and anomalous x-ray diffraction data collection.

Pre-grown TPST2Na crystals were transferred into soaking solution [0.1 M HEPES-NaOH pH 7.0, 16% (w/v) PEG 6000, 1 mM ZnCl2 and 0.1 M potassium sodium tartrate] supplemented with 10 mM CoCl2​, ZnCl2​, or CuCl2​ for 30 min to 3 h at 20 °C. After soaking, crystals were briefly back-soaked in reservoir solution before cryo-cooling.

To confirm metal binding, single-wavelength anomalous diffraction (SAD) data were collected at the respective K-edge peak wavelengths of Mn (λ = 1.8933 Å), Co (λ = 1.6054 Å), Zn (λ = 1.2824 Å), and Cu (λ = 1.3785 Å). Diffraction data sets [data titles: Mn (ano), Co (ano), Zn (ano), Cu (ano)] were indexed, integrated and scaled using the HKL suite and XDS package. Molecular replacement was carried out with Phaser-MR in the PHENIX package using the TPST2Na structure (PDB ID: 9WWE) as the search model. Anomalous difference Fourier maps were calculated with phenix.maps and subsequently inspected in Coot to identify the bound metal ions. Details of the data collection statistics are summarized in Table 1.

Structural analysis

PyMOL44 version 2.5.0 was used for all structural analyses and figures. Multiple sequence alignment was performed using Jalview45, with multiple alignment and conservation analyses executed through the JABAWS web service framework46,47. Metal-binding geometries were assessed and the cation assignments validated using the CheckMyMetal31 (CMM) and MetalPDB32 servers; full CMM reports for each site and condition are provided in Supplementary Fig. 6. Interface areas and oligomerization states were analyzed with PDBePISA48.

Ensemble refinement and RMSF analysis

Ensemble refinement of TPST2 structures was carried out with phenix.ensemble_refinement49, using structure factors and coordinates as input. The simulations comprised an equilibration phase of 6 ps (10 τx periods, 1200 macro cycles), during which temperature, X-ray weight and averaged structure factors stabilized, followed by an acquisition phase of 12 ps (20 τx periods, 2400 macro cycles). The combined 18 ps trajectories were used to generate ensemble models. RMSF values were calculated from the ensemble coordinates. To normalize structural fluctuations and allow chain-wise comparison, we additionally computed Z-RMSF values, defined as residue-wise RMSF values standardized by subtracting the mean and dividing by the standard deviation across all residues50. The ensembles were visualized in PyMOL (v2.5.0) using ens_tool.py.

BioEmu analysis

BioEmu33 was employed to generate equilibrium ensembles of TPST2 using the ColabFold51 BioEmu notebook. A total of 1000 structural samples were generated using its diffusion-based sampling protocol. Residue-wise RMSF values were computed from the BioEmu ensembles.

Thermal stability assay

The melting temperature of hTPST2 was determined spectrophotometrically as described previously52. Briefly, 50 µL of 50 µM purified protein in buffer D were introduced into PER tubes, and the temperature was raised at a rate of 4 °C per 90 s using a Thermal Cycler Dice Gradient (Takara Bio, Inc). Turbidity was quantified by measuring absorbance at 470 nm with a Nanodrop-2000 spectrophotometer (Thermo Fisher Scientific, Inc). The dose-response curve was fitted using Veusz 4.1. All experiments were conducted in triplicate (n = 3). Data are presented as the mean ± 95% confidence interval (CI).

Evaluation of hTPST2 enzyme activity.

Enzyme activity of hTPST2 was assayed as described previously53. hTPST2 activity was measured using a Universal Sulfotransferase Activity Kit (R&D Systems, EA003). The reaction buffer contained 50 mM Tris-HCl (pH 7.0), 15 mM MgCl₂, 20 mM NaCl, 0.75 mg/mL BSA, and 0.1% Triton X-100. Reaction mixtures containing TPST2 (30 nM), PAPS (100 µM; R&D Systems, ES019), C4 peptide substrate (100 µM; Chempeptide, EDFEDYEFD), and IMPAD1 (10 ng/µL; R&D Systems, EA003) were prepared and dispensed into a 96-well clear-bottom plate (SPL, 31096) at 50 µL per well. The plate was then incubated at 20 °C for 0–5 h. After incubation, 160 µL of a freshly prepared mixture of Malachite Green Reagent A, distilled water, and Reagent B [3:10:3 (v/v); R&D Systems, EA003] was added to each well and incubated for an additional 1 h at 20 °C. Absorbance was measured at 630 nm using a FlexStation 3 Multimode Microplate Reader (Molecular Devices). The amount of phosphate produced was determined from the absorbance values using a standard curve generated with phosphate standard solutions (R&D Systems, EA003).

Statistics and reproducibility

All biochemical assays were performed in at least three independent replicates. Thermal shift assay data are presented as the mean ± 95% confidence interval (CI), and enzymatic activity data as the mean ± standard error of the mean (SEM). Structural refinements and RMSF analyses were reproduced with independent datasets.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1 (93.5KB, xls)

Acknowledgements

We gratefully acknowledge the staff at beamlines BL-5 C and 11 C at the PAL for their kind help with data collection. This research was supported by the National Research Foundation (NRF) of the Korean government (NRF-2021R1A2C1006267) and by the Bio&Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (RS-2024-00344154 and RS-2024-00440614).

Author contributions

S.H.E. and M.J. conceived the study and organized experiments; M.J. performed most experiments; C.N., J.Y., and H.K. contributed to X-ray diffraction experiments and data analysis; S.B.P. contributed to enzyme activity assays and analysis; S.H.E. and Y.C.K. provided advice and guidance. All authors contributed to the interpretation of the results and preparation of the manuscript.

Funding

This research was supported by the National Research Foundation (NRF) of the Korean government (NRF-2021R1A2C1006267) and by the Bio&Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (RS-2024-00344154 and RS-2024-00440614).

Data availability

The coordinates and structural factors for TPST2 Na and TPST2 Mn have been deposited in the Protein Data Bank under accession codes 9WWE and 9WWF (PDB DOI: https://doi.org/10.2210/pdb9WWE/pdb and https://doi.org/10.2210/pdb9WWF/pdb). The source data underlying the graphs presented in the paper are provided in Supplementary Data 1. All other data are available from the corresponding author upon reasonable request.

Declarations

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

6. References

  • 1.Lee, R. & Huttner, W. Tyrosine-O-sulfated proteins of PC12 pheochromocytoma cells and their sulfation by a tyrosylprotein sulfotransferase. J. Biol. Chem.258, 11326–11334 (1983). [PubMed] [Google Scholar]
  • 2.Baeuerle, P. A. & Huttner, W. B. Tyrosine sulfation is a trans-Golgi-specific protein modification. J. Cell. Biol.105, 2655–2664 (1987). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Huttner, W. B. Tyrosine sulfation and the secretory pathway. Annu. Rev. Physiol.50, 363–376 (1988). [DOI] [PubMed] [Google Scholar]
  • 4.Lipmann, F. Biological sulfate activation and transfer: studies on a mechanism of group activation and its role in biosynthesis are described. Science128, 575–580 (1958). [DOI] [PubMed] [Google Scholar]
  • 5.Yang, Y. S. et al. Tyrosine sulfation as a protein post-translational modification. Molecules20, 2138–2164 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Hille, A., Braulke, T., von FIGURA, K. & Huttner, W. B. Occurrence of tyrosine sulfate in proteins–a balance sheet: 1. Secretory and lysosomal proteins. Eur. J. Biochem.188, 577–586 (1990). [DOI] [PubMed] [Google Scholar]
  • 7.Hille, A. & Huttner, W. B. Occurrence of tyrosine sulfate in proteins–a balance sheet: 2. Membrane proteins. Eur. J. Biochem.188, 587–596 (1990). [DOI] [PubMed] [Google Scholar]
  • 8.Kehoe, J. W. & Bertozzi, C. R. Tyrosine sulfation: a modulator of extracellular protein–protein interactions. Chem. Biol.7, R57–R61 (2000). [DOI] [PubMed] [Google Scholar]
  • 9.Huttner, W. B. Sulphation of tyrosine residues—a widespread modification of proteins. Nature299, 273–276 (1982). [DOI] [PubMed] [Google Scholar]
  • 10.Moore, K. L. The biology and enzymology of protein tyrosine O-sulfation. J. Biol. Chem.278, 24243–24246 (2003). [DOI] [PubMed] [Google Scholar]
  • 11.Stewart, V. & Ronald, P. C. Sulfotyrosine residues: interaction specificity determinants for extracellular protein–protein interactions. J. Biol. Chem.298, 102232 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ouyang, Y., Lane, W. S. & Moore, K. L. Tyrosylprotein sulfotransferase: purification and molecular cloning of an enzyme that catalyzes tyrosine O-sulfation, a common posttranslational modification of eukaryotic proteins. Proc. Natl. Acad. Sci. USA. 95, 2896–2901 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Beisswanger, R. et al. Existence of distinct tyrosylprotein sulfotransferase genes: molecular characterization of tyrosylprotein sulfotransferase-2. Proc. Natl. Acad. Sci. USA. 95, 11134–11139 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ouyang, Y. B. & Moore, K. L. Molecular cloning and expression of human and mouse tyrosylprotein sulfotransferase-2 and a tyrosylprotein sulfotransferase homologue in caenorhabditis elegans. J. Biol. Chem.273, 24770–24774 (1998). [DOI] [PubMed] [Google Scholar]
  • 15.Kakuta, Y., Pedersen, L. G., Pedersen, L. C. & Negishi, M. Conserved structural motifs in the sulfotransferase family. Trends Biochem. Sci.23, 129–130 (1998). [DOI] [PubMed] [Google Scholar]
  • 16.Teramoto, T. et al. Crystal structure of human tyrosylprotein sulfotransferase-2 reveals the mechanism of protein tyrosine sulfation reaction. Nat. Commun.4, 1572 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tanaka, S. et al. Structural basis for the broad substrate specificity of the human tyrosylprotein sulfotransferase-1. Sci. Rep.7, 8776 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lee, R. & Huttner, W. B. (Glu62, Ala30, Tyr8)n serves as high-affinity substrate for tyrosylprotein sulfotransferase: a Golgi enzyme. Proc. Natl. Acad. Sci. USA82, 6143–6147 (1985). [DOI] [PMC free article] [PubMed]
  • 19.Niehrs, C. & Huttner, W. B. Purification and characterization of tyrosylprotein sulfotransferase. EMBO J.9, 35–42 (1990). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bundgaard, J. R., Vuust, J. & Rehfeld, J. F. New consensus features for tyrosine O-sulfation determined by mutational analysis. J. Biol. Chem.272, 21700–21705 (1997). [DOI] [PubMed] [Google Scholar]
  • 21.Yoshimura, M. et al. Crystal structure of tick tyrosylprotein sulfotransferase reveals the activation mechanism of the tick anticoagulant protein Madanin. J Biol. Chem.300 (2024). [DOI] [PMC free article] [PubMed]
  • 22.Westmuckett, A. D., Hoffhines, A. J., Borghei, A. & Moore, K. L. Early postnatal pulmonary failure and primary hypothyroidism in mice with combined TPST-1 and TPST-2 deficiency. Gen. Comp. Endocrinol.156, 145–153 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Borghei, A. et al. Targeted disruption of tyrosylprotein sulfotransferase-2, an enzyme that catalyzes post-translational protein tyrosine O-sulfation, causes male infertility. J. Biol. Chem.281, 9423–9431 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Sasaki, N. et al. A mutation in Tpst2 encoding tyrosylprotein sulfotransferase causes dwarfism associated with hypothyroidism. Mol. Endocrinol.21, 1713–1721 (2007). [DOI] [PubMed] [Google Scholar]
  • 25.Mishiro, E., Sakakibara, Y., Liu, M. C. & Suiko, M. Differential enzymatic characteristics and tissue-specific expression of human TPST-1 and TPST-2. J. Biochem.140, 731–737 (2006). [DOI] [PubMed] [Google Scholar]
  • 26.Oh, Y. et al. Genome-wide CRISPR screening identifies tyrosylprotein sulfotransferase-2 as a target for augmenting anti-PD1 efficacy. Mol. Cancer. 23, 155 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Cai, X. et al. Inhibition of the SLC35B2-TPST2 axis of tyrosine sulfation attenuates the growth and metastasis of pancreatic ductal adenocarcinom. Cell. Mol. Gastroenterol. Hepatol.16, 473–495 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ujiie, K. et al. Specific recognition mechanism of an antibody to sulfated tyrosine and its potential use in biological research. J. Biol. Chem.301 (2025). [DOI] [PMC free article] [PubMed]
  • 29.Kasinathan, C., Rizwan, M., Slomiany, A. & Slomiany, B. L. Effect of sofalcone on tyrosylprotein sulfotransferase. Gen. Pharmacol.25, 1017–1020 (1994). [DOI] [PubMed] [Google Scholar]
  • 30.Byrne, D. P. et al. New tools for evaluating protein tyrosine sulfation: tyrosylprotein sulfotransferases (TPSTs) are novel targets for RAF protein kinase inhibitors. Biochem. J.475, 2435–2455 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Gucwa, M. et al. CMM—An enhanced platform for interactive validation of metal binding sites. Protein Sci.32, e4525 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Putignano, V., Rosato, A., Banci, L. & Andreini, C. MetalPDB in 2018: a database of metal sites in biological macromolecular structures. Nucleic Acids Res.46, D459–D464 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lewis, S. et al. Scalable emulation of protein equilibrium ensembles with generative deep learning. Science389, eadv9817 (2025). [DOI] [PubMed] [Google Scholar]
  • 34.Das, S. et al. Manganese mapping using a fluorescent Mn2+ sensor and Nanosynchrotron X-ray fluorescence reveals the role of the golgi apparatus as a manganese storage site. Inorg. Chem.58 (20), 13724–13732 (2019). [DOI] [PubMed] [Google Scholar]
  • 35.Potelle, S. et al. Glycosylation abnormalities in Gdt1p/TMEM165 deficient cells result from a defect in golgi manganese homeostasis. Hum. Mol. Genet.25 (8), 1489–1500 (2016). [DOI] [PubMed] [Google Scholar]
  • 36.Potelle, S. et al. Manganese-induced turnover of TMEM165. Biochem. J.474 (9), 1481–1493 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Jankauskas, S. S. et al. Insights into molecular and cellular functions of the golgi calcium/manganese-proton antiporter TMEM165. J. Biol. Chem.300 (8), 107567 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kabsch, W. Acta Crystallogr. Sect. D Biol. Crystallogr.66, 125–132 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Otwinowski, Z. & Minor, W. Methods Enzymol.276, 307–326 (1997). [DOI] [PubMed] [Google Scholar]
  • 40.McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Crystallogr.40, 658–674 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in phenix. Acta Crystallogr. Sect. D Struct. Biol.75, 861–877 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Agirre, J. et al. The CCP4 suite: integrative software for macromolecular crystallography. Acta Crystallogr. Sect. D Struct. Biol.79, 449–461 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D Biol. Crystallogr.66, 486–501 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Schrodinger, L. The PyMOL molecular graphics system. Version1, 8 (2015). [Google Scholar]
  • 45.Waterhouse, A. M., Procter, J. B., Martin, D. M., Clamp, M. & Barton, G. J. Jalview version 2—a multiple sequence alignment editor and analysis workbench. Bioinformatics25, 1189–1191 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Troshin, P. V., Procter, J. B. & Barton, G. J. Java bioinformatics analysis web services for multiple sequence alignment—JABAWS. MSA Bioinformatics. 27, 2001–2002 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Troshin, P. V. et al. JABAWS 2.2 distributed web services for bioinformatics: protein disorder, conservation and RNA secondary structure. Bioinformatics34, 1939–1940 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol.372, 774–797 (2007). [DOI] [PubMed] [Google Scholar]
  • 49.Burnley, B. T., Afonine, P. V., Adams, P. D. & Gros, P. Modelling dynamics in protein crystal structures by ensemble refinement. Elife1, e00311 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Song, X. et al. Accurate prediction of protein structural flexibility by deep learning integrating intricate atomic structures and Cryo-EM density information. Nat. Commun.15, 5538 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Mirdita, M. et al. ColabFold: making protein folding accessible to all. Nat. Methods. 19, 679–682 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Jin, M., Yang, J., Park, J., Kim, H. & Eom, S. H. Structure of MICU from non-metazoan dictyostelium discoideum reveals unique characteristics. Commun. Biol.8, 782 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Park, S. B. et al. Discovery of (4-Phenyl-cyclohexyl) acetate-Derived tyrosylprotein sulfotransferase 2 (TPST2) inhibitors with potent anti-tumor activity for immuno-oncology applications. J. Med. Chem. (2025). [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 1 (93.5KB, xls)

Data Availability Statement

The coordinates and structural factors for TPST2 Na and TPST2 Mn have been deposited in the Protein Data Bank under accession codes 9WWE and 9WWF (PDB DOI: https://doi.org/10.2210/pdb9WWE/pdb and https://doi.org/10.2210/pdb9WWF/pdb). The source data underlying the graphs presented in the paper are provided in Supplementary Data 1. All other data are available from the corresponding author upon reasonable request.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES